{"id":"https://openalex.org/W2275199929","doi":"https://doi.org/10.1093/neuonc/nov306","title":"LB-05PHASE III TRIAL EXPLORING THE COMBINATION OF BEVACIZUMAB AND LOMUSTINE IN PATIENTS WITH FIRST RECURRENCE OF A GLIOBLASTOMA: THE EORTC 26101 TRIAL","display_name":"LB-05PHASE III TRIAL EXPLORING THE COMBINATION OF BEVACIZUMAB AND LOMUSTINE IN PATIENTS WITH FIRST RECURRENCE OF A GLIOBLASTOMA: THE EORTC 26101 TRIAL","publication_year":2015,"publication_date":"2015-11-01","ids":{"openalex":"https://openalex.org/W2275199929","doi":"https://doi.org/10.1093/neuonc/nov306","mag":"2275199929"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/nov306","doi":"https://doi.org/10.1093/neuonc/nov306","is_oa":false,"landing_page_url":"https://doi.org/10.1093/neuonc/nov306","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080482957","display_name":"Wolfgang Wick","orcid":"https://orcid.org/0000-0002-6171-634X","observed_orcids":["https://orcid.org/0000-0002-6171-634X"]},"institutions":[{"id":"https://openalex.org/I17937529","display_name":"German Cancer Research Center","ror":"https://ror.org/04cdgtt98","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"W. Wick","raw_affiliation_strings":["University Medical Center & German Cancer Research Center, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Medical Center & German Cancer Research Center, Heidelberg, Germany","institution_ids":["https://openalex.org/I17937529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103893703","display_name":"Aa Brandes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123211","display_name":"Istituto delle Scienze Neurologiche di Bologna","ror":"https://ror.org/02mgzgr95","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210119117","https://openalex.org/I4210123211","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"AA. Brandes","raw_affiliation_strings":["Medical Oncology Department, AUSL-Bologna-IRCCS Scienze Neurologiche, Bologna, Italia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, AUSL-Bologna-IRCCS Scienze Neurologiche, Bologna, Italia","institution_ids":["https://openalex.org/I4210123211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038129366","display_name":"Thierry Gorlia","orcid":"https://orcid.org/0009-0009-9159-2761","observed_orcids":["https://orcid.org/0009-0009-9159-2761"]},"institutions":[{"id":"https://openalex.org/I4210124801","display_name":"European Organisation for Research and Treatment of Cancer","ror":"https://ror.org/034wxcc35","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I4210124801"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"T. Gorlia","raw_affiliation_strings":["EORTC Headquarters, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EORTC Headquarters, Brussels, Belgium","institution_ids":["https://openalex.org/I4210124801"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019876508","display_name":"Martin Bendszus","orcid":"https://orcid.org/0000-0002-9094-6769","observed_orcids":["https://orcid.org/0000-0002-9094-6769"]},"institutions":[{"id":"https://openalex.org/I17937529","display_name":"German Cancer Research Center","ror":"https://ror.org/04cdgtt98","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M. Bendszus","raw_affiliation_strings":["University Medical Center & German Cancer Research Center, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Medical Center & German Cancer Research Center, Heidelberg, Germany","institution_ids":["https://openalex.org/I17937529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063978061","display_name":"Felix Sahm","orcid":"https://orcid.org/0000-0001-5441-1962","observed_orcids":["https://orcid.org/0000-0001-5441-1962"]},"institutions":[{"id":"https://openalex.org/I17937529","display_name":"German Cancer Research Center","ror":"https://ror.org/04cdgtt98","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"F. Sahm","raw_affiliation_strings":["University Medical Center & German Cancer Research Center, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Medical Center & German Cancer Research Center, Heidelberg, Germany","institution_ids":["https://openalex.org/I17937529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026126995","display_name":"Walter Taal","orcid":"https://orcid.org/0000-0002-5530-7259","observed_orcids":["https://orcid.org/0000-0002-5530-7259"]},"institutions":[{"id":"https://openalex.org/I4405267285","display_name":"Daniel den Hoed Kliniek","ror":"https://ror.org/020rz5h24","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908","https://openalex.org/I4405267285"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"W. Taal","raw_affiliation_strings":["Daniel den Hoed Cancer Center, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Daniel den Hoed Cancer Center, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I4405267285"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056837393","display_name":"MARTIN J.B. TAPHOORN","orcid":"https://orcid.org/0000-0001-9949-4722","observed_orcids":["https://orcid.org/0000-0001-9949-4722"]},"institutions":[{"id":"https://openalex.org/I4210097307","display_name":"Medisch Centrum Haaglanden","ror":"https://ror.org/00v2tx290","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210097307","https://openalex.org/I4210130725"]},{"id":"https://openalex.org/I4405267360","display_name":"Stichting Haaglanden Medisch Centrum","ror":"https://ror.org/02d8x6563","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4405267360"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M. Taphoorn","raw_affiliation_strings":["Medical Center Haaglanden, The Hague, The Netherlands The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Center Haaglanden, The Hague, The Netherlands The Netherlands","institution_ids":["https://openalex.org/I4210097307","https://openalex.org/I4405267360"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049799682","display_name":"Julien D\u00f4mont","orcid":"https://orcid.org/0009-0008-1214-1835","observed_orcids":["https://orcid.org/0009-0008-1214-1835"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J. Domont","raw_affiliation_strings":["Institut Gustave Roussy, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Gustave Roussy, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100629734","display_name":"Ahmed Idba\u00efh","orcid":"https://orcid.org/0000-0001-5290-1204","observed_orcids":["https://orcid.org/0000-0001-5290-1204"]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210121705","display_name":"Piti\u00e9-Salp\u00eatri\u00e8re Hospital","ror":"https://ror.org/02mh9a093","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210121705"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Idbaih","raw_affiliation_strings":["AP-HP, H\u00f4pital Universitaire La Piti\u00e9 Salp\u00eari\u00e8re and Sorbonne Universit\u00e9s, UPMC Univ Paris 06, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AP-HP, H\u00f4pital Universitaire La Piti\u00e9 Salp\u00eari\u00e8re and Sorbonne Universit\u00e9s, UPMC Univ Paris 06, Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210121705","https://openalex.org/I4405264447"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071553983","display_name":"Mario Campone","orcid":"https://orcid.org/0000-0002-5196-5908","observed_orcids":["https://orcid.org/0000-0002-5196-5908"]},"institutions":[{"id":"https://openalex.org/I4210106090","display_name":"Institut de Canc\u00e9rologie de l'Ouest","ror":"https://ror.org/01m6as704","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210106090"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Campone","raw_affiliation_strings":["Institut de Cancerologie de l'Ouest (ICO) - Centre Rene Gauducheau, Saint-Herblain, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut de Cancerologie de l'Ouest (ICO) - Centre Rene Gauducheau, Saint-Herblain, France","institution_ids":["https://openalex.org/I4210106090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001037498","display_name":"Paul M. Cl\u00e9ment","orcid":"https://orcid.org/0000-0001-7600-0806","observed_orcids":["https://orcid.org/0000-0001-7600-0806"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"P.M. Clement","raw_affiliation_strings":["U.Z. Leuven - KU Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.Z. Leuven - KU Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053052330","display_name":"Roger Stupp","orcid":"https://orcid.org/0000-0002-5483-3118","observed_orcids":["https://orcid.org/0000-0002-5483-3118"]},"institutions":[{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"R. Stupp","raw_affiliation_strings":["Zurich University Medical Center, Zurich, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zurich University Medical Center, Zurich, Switzerland","institution_ids":["https://openalex.org/I4210100468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086083902","display_name":"Michel Fabbro","orcid":"https://orcid.org/0000-0003-1910-4777","observed_orcids":["https://orcid.org/0000-0003-1910-4777"]},"institutions":[{"id":"https://openalex.org/I4387154388","display_name":"Institut Regional du Cancer de Montpellier","ror":"https://ror.org/02693j602","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210141925","https://openalex.org/I4387154388"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Fabbro","raw_affiliation_strings":["Institut r\u00e9gional du Cancer Montpellier, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut r\u00e9gional du Cancer Montpellier, Montpellier, France","institution_ids":["https://openalex.org/I4387154388"]}]},{"author_position":"middle","author":{"id":null,"display_name":"F. Dubois","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"F. Dubois","raw_affiliation_strings":["CHRU de Lille, Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHRU de Lille, Lille, France","institution_ids":["https://openalex.org/I3018718406"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003817127","display_name":"Carlos Bais","orcid":"https://orcid.org/0000-0002-3668-4227","observed_orcids":["https://orcid.org/0000-0002-3668-4227"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Bais","raw_affiliation_strings":["Genentech Inc., South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074755682","display_name":"Davide Musmeci","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124801","display_name":"European Organisation for Research and Treatment of Cancer","ror":"https://ror.org/034wxcc35","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I4210124801"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"D. Musmeci","raw_affiliation_strings":["EORTC Headquarters, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EORTC Headquarters, Brussels, Belgium","institution_ids":["https://openalex.org/I4210124801"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064778456","display_name":"Michael Platten","orcid":"https://orcid.org/0000-0002-4746-887X","observed_orcids":["https://orcid.org/0000-0002-4746-887X"]},"institutions":[{"id":"https://openalex.org/I17937529","display_name":"German Cancer Research Center","ror":"https://ror.org/04cdgtt98","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M. Platten","raw_affiliation_strings":["University Medical Center & German Cancer Research Center, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Medical Center & German Cancer Research Center, Heidelberg, Germany","institution_ids":["https://openalex.org/I17937529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017177249","display_name":"Michael Weller","orcid":"https://orcid.org/0000-0002-1748-174X","observed_orcids":["https://orcid.org/0000-0002-1748-174X"]},"institutions":[{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"M. Weller","raw_affiliation_strings":["Zurich University Medical Center, Zurich, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zurich University Medical Center, Zurich, Switzerland","institution_ids":["https://openalex.org/I4210100468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109476974","display_name":"V. Golfinopoulos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124801","display_name":"European Organisation for Research and Treatment of Cancer","ror":"https://ror.org/034wxcc35","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I4210124801"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"V. Golfinopoulos","raw_affiliation_strings":["EORTC Headquarters, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EORTC Headquarters, Brussels, Belgium","institution_ids":["https://openalex.org/I4210124801"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010891460","display_name":"Martin J. van den Bent","orcid":"https://orcid.org/0000-0001-5710-5127","observed_orcids":["https://orcid.org/0000-0001-5710-5127"]},"institutions":[{"id":"https://openalex.org/I4405267285","display_name":"Daniel den Hoed Kliniek","ror":"https://ror.org/020rz5h24","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908","https://openalex.org/I4405267285"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M. van den Bent","raw_affiliation_strings":["Daniel den Hoed Cancer Center, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Daniel den Hoed Cancer Center, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I4405267285"]}]}],"institutions":[],"countries_distinct_count":7,"institutions_distinct_count":16,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":10.6416,"has_fulltext":true,"cited_by_count":80,"citation_normalized_percentile":{"value":0.99169808,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"17","issue":"suppl 5","first_page":"v1.5","last_page":"v1"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.925000011920929},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.8370000123977661},{"id":"https://openalex.org/keywords/lomustine","display_name":"lomustine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/first-recurrence","display_name":"first recurrence","score":0.6669999957084656},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.43700000643730164},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9279999732971191},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9980000257492065},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.8169999718666077},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.5419999957084656},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5070000290870667},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.7599999904632568},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.367000013589859},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.6679999828338623}],"concepts":[{"id":"https://openalex.org/C2779434656","wikidata":"https://www.wikidata.org/wiki/Q415378","display_name":"Lomustine","level":5,"score":0.9589254260063171},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.922797679901123},{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.7996101379394531},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6996108889579773},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6763915419578552},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.641292929649353},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2053268551826477},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.1989574432373047},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.06936252117156982},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/neuonc/nov306","doi":"https://doi.org/10.1093/neuonc/nov306","is_oa":false,"landing_page_url":"https://doi.org/10.1093/neuonc/nov306","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:doc.rero.ch:301206","doi":null,"is_oa":false,"landing_page_url":"http://doc.rero.ch/record/301206/files/nov306.pdf","pdf_url":"http://doc.rero.ch/record/301206/files/nov306.pdf","source":{"id":"https://openalex.org/S4306400148","display_name":"reroDoc Digital Library","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2587255795","https://openalex.org/W2512596242","https://openalex.org/W2588571677","https://openalex.org/W2510787410","https://openalex.org/W4233128425","https://openalex.org/W2942024685","https://openalex.org/W2068854626","https://openalex.org/W2768886569","https://openalex.org/W2333764022","https://openalex.org/W2074515895"],"abstract_inverted_index":{"BACKGROUND:":[0],"Phase":[1],"II":[2],"data":[3],"from":[4,360],"the":[5,10,39,50,88,133,142,146,149,163,197,203,216,248,283,287,294,301,318,326],"BELOB":[6],"trial":[7],"indicated":[8],"that":[9,361],"combination":[11,147,204,217,284,302,327],"of":[12,32,38,43,52,64,135,151,180,191,250,315,323],"bevacizumab":[13,53,108,251,311,330],"and":[14,112,175,183,200,272],"lomustine":[15,55,71,95,113,152,198,253,288],"might":[16],"produce":[17],"an":[18],"overall":[19,57],"survival":[20,243,348],"(OS)":[21],"benefit":[22,359],"compared":[23,67],"with":[24,29,61,70,75,81,247,297,338],"either":[25],"monotherapy":[26],"for":[27],"patients":[28,60,186,316,324,337,357],"first":[30,62,143],"progression":[31,63],"a":[33,65,169,347],"glioblastoma.":[34],"The":[35,350],"primary":[36],"objective":[37],"phase":[40],"III":[41],"part":[42,90],"EORTC":[44,235],"26101":[45],"is":[46,353],"to":[47,54,68,156,168,252,310,354],"investigate":[48],"whether":[49],"addition":[51,249],"improves":[56],"OS":[58,208,211,263],"in":[59,145,162,196,202,215,282,293,300,313,317,325,336],"glioblastoma":[66,340],"treatment":[69,192,335],"alone.":[72],"METHODS:":[73],"Patients":[74],"progressive":[76,339],"disease":[77],"after":[78],"standard":[79,170],"chemo-radiotherapy":[80],"temozolomide":[82],"at":[83,129,331],"least":[84],"3":[85,201],"months":[86,271,281],"off":[87],"concomitant":[89],"were":[91,187],"randomized":[92],"2:1":[93],"between":[94],"90":[96],"mg/m2":[97,117,158],"(cap.":[98,118],"160":[99],"mg)":[100,120,161],"mg":[101],"every":[102,109,121],"six":[103,122],"weeks":[104,111,123],"plus":[105],"10":[106],"mg/kg":[107],"two":[110],"single":[114],"agent":[115],"110":[116,157],"200":[119,160],"followed":[124],"by":[125,234],"best":[126],"investigators":[127],"choice":[128],"further":[130],"progression.":[131,332],"In":[132],"absence":[134],"hematological":[136],"toxicity":[137],">":[138],"grade":[139],"1":[140,195],"during":[141],"cycle":[144],"arms,":[148],"dose":[150],"could":[153],"be":[154],"escalated":[155],"(cap":[159],"second":[164],"cycle.":[165],"Neuroimaging":[166],"according":[167],"protocol":[171],"was":[172,194,212,245,292],"assessed":[173,241],"locally":[174,240],"centrally.":[176],"RESULTS:":[177],"A":[178],"total":[179],"437":[181],"(288":[182],"149,":[184],"respectively)":[185],"included.":[188],"Median":[189,259],"number":[190],"cycles":[193],"arm":[199,219,285,289,303,328],"arm.":[205],"With":[206],"329":[207],"events":[209,299],"(75.3%)":[210],"not":[213,345],"superior":[214],"therapy":[218],"(hazard":[220],"ratio":[221],"(HR)":[222],"0.95":[223],"(confidence":[224],"interval":[225],"(CI)":[226],"0.74,":[227],"1.21),":[228],"p":[229],"=":[230],"0.650,":[231],"analyses":[232],"stratified":[233],"online":[236],"randomization":[237],"system),":[238],"whereas":[239,321],"progression-free":[242],"(PFS)":[244],"longer":[246,306],"(HR":[254],"0.49":[255],"(CI":[256],"0.39,":[257],"0.61).":[258],"efficacy":[260],"outcomes":[261],"were:":[262],"9.1":[264],"(8.1,":[265],"10.1)":[266],"versus":[267,277,286],"8.6":[268],"(7.6,":[269],"10.4)":[270],"PFS":[273,343],"4.2":[274],"(3.7,":[275],"4.3)":[276],"1.5":[278],"(1.5,":[279],"2.5)":[280],"respectively.":[290],"Toxicity":[291],"expected":[295],"range":[296],"more":[298],"being":[304],"also":[305],"on":[307],"treatment.":[308,362],"Crossover":[309],"occurred":[312],"35.5%":[314],"control":[319],"arm;":[320],"19%":[322],"continued":[329],"CONCLUSIONS:":[333],"Bevacizumab":[334],"despite":[341],"prolonged":[342],"does":[344],"confer":[346],"advantage.":[349],"future":[351],"challenge":[352],"identify":[355],"those":[356],"deriving":[358]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":19},{"year":2016,"cited_by_count":40},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}